Philippine Standard Time
Thursday, August 13, 2020
12:56 pm

Downloads - Policies Page



Reference Number File Name
AO 2020-0026 Guidelines on Integrating Existing Protocols on Tuberculosis (TB) and Diabetes Mellitus (DM) Case Finding and Management Activities.
AO 2020-0025 Policy and Guidelines on the Implementation of Active Drug Safety Monitoring and Management (aDSM) of the National Tuberculosis Control Program.
AO 2019-0051 Reconstitution of the Philippine Country Coordinating Mechanism (PCCM) in support of the Implementation of the Global Fund to Fight Against AIDS, TB and Malaria (GFATM) Grants in the Philippines.
AO 2017-0021 Guidelines for the Operationalization of the Single Joints Ethics Review Process for Multi-site Researches in the Department of Health.
AO 2016-0040 Revised Policies and Guidelines on the Implementation of the Programmatic Management of Drug-Resistant TB (PMDT).
AO 2016-0038 The Philippine Health Agenda 2016-2022.
AO 2015-0039 Guidelines for Managing Tuberculosis Control Program During Emergencies and Disasters.
AO 2015-0032 Revised Technical Guidelines for Implementing DOTS Strategies in Jails and Prisons.
AO 2015-0029 Revised Policies and Guidelines on Hospital TB-DOTS under the National TB Control Program.
AO 2015-0024 Implementing Guidelines on Integrated Tuberculosis Information System (ITIS).
AO 2014-0032 Guidelines for the Scaling-up and Use of Xpert MTB/RIF as Rapid TB Diagnostic Tool under the National TB Control Program.
AO 2014-0005 Revised Policies and Guidelines in the Collaborative Approach of TB and HIV Prevention and Control.
AO 2010-0031 Adoption of the 2010-2016 Philippine Plan of Action to Control Tuberculosis (PhilPACT) and Its Implementing Structures.
AO 2009-0024 Reconstitution of the Country Coordinating Mechanism (CCM) in Support of the Implementation of the Global Fund to Fight Against AIDS, TB and Malaria (GFATM) Grants in the Philippines.
AO 2009-0003 Technical Guidelines for Implementing DOTS Strategy in Jails and Prisons.
AO 2008-0022 Policies and Guidelines in the Collaborative Approach of TB and HIV Prevention and Control.
AO 2008-0018 Guidelines for the Implementation of the Programmatic Management of Drug Resistant Tuberculosis (PMDT).
AO 2008-0011 Revised Guidelines for Implementing Tuberculosis Control Program in Children.
AO 2007-0019 Guidelines for the Implementation of the Quality Assurance System on Direct Sputum Smear Microscopy (DSSM).
AO 2006-0026 Implementing Guidelines in the Conduct of the National TB Control Program – Directly Observed Treatment Short-Course (NTP-DOTS) Certification.
AO 140-04 Revised Guidelines for Hospital-Based TB Control Program Under the Hospitals as Centers of Wellness Program.
AO 150 Amendment to AO No. 39 s. 1999 dated September 2, 1999.
AO 60-00 Guidelines on the Procurement of Anti-TB Drugs for the National TB Program Using 2000 Regional Funds.
AO 19-99 Guidelines on the Utilization of Funds (Sub-allotment) for the Procurement and Distribution of Anti-TB Drugs for the National TB Control Program Using 1998 CONAP and 1999 GAA.
AO 25-98a Guidelines for the Procurement of Anti-TB Drugs at the Regional Health Offices using the 1998 National Tuberculosis program (NTP) funds.
AO 26-98 Addendum to Administrative Order No. 25 s. 1998 re: Guidelines for the procurement of anti-TB drugs at the Regional Health Offices using the 1998 National Tuberculosis Program (NTP) funds.
AO 24A-97 Guidelines in the Implementation of Hospital-Based TB Control Program under the Hospital as Centers of Wellness Program.
AO 24-96 Guidelines on the implementation of the Directly Observed Treatment of Short Course Chemotherapy (D.O.T.S) or “Tutok Gamutan” of TB Patients.
Reference Number File Name
DO 2020-0078 Guidelines on the Release and Utilization of Funds from the Disease Prevention and Control Bureau - National Tuberculosis Control Program to Centers for Health Development for National Tuberculosis Control Program Activities.
DO 2017-0266 Guidelines on the Sub-allotment and Utilization of Fund for the Regionalization of the Philippine Strategic TB Elimination Plan Phase 1 (PhilSTEP1) in Region II.
DO 2017-0265 Guidelines for the Streamlined Research Ethics Review Process in the Department of Health.
DO 2017-0237-A Amendment to Department Order No. 2017-0237 dated June 9, 2017 entitled "Guidelines on the Sub-allotment and Utilization of Funds from the National TB Control Program to Regional Office VI".
DO 2017-0237 Guidelines on the Sub-allotment and Utilization of Funds from the National TB Control Program to Regional Office VI.
DO 2017-0236 Guidelines on the Implementation of the Freedom of Information (FOI) Program and Open Data Initiative (ODI) in the DOH.
DO 2017-0233-A Amendment to Department Order No. 2017-0233 dated June 9, 2017 entitled " Guidelines on the Sub-allotment and Utilization of Funds from the National TB Control Program to the Philippine Orthopedic Center".
DO 2017-0233 Guidelines on the Sub-allotment and Utilization of Funds from the National TB Control Program to Philippine Orthopedic Center.
DO 2017-0196 Guidelines on the Utilization of Sub-allotted Funds from the National Tuberculosis Control Program to Selected Regional TB Culture Centers and the Research Institute for Tropical Medicine - National TB Reference Laboratory for the Conduct of the 3rd Drug Resistance Survey in 2018.
DO 2017-0195 Guidelines on the Sub-Allotment and Utilization of Funds from the National Tuberculosis Program to DOH-Regional Offices.
DO 2017-0146 Guidelines on the Utilization of Fund Sub-allotment from the National TB Control Program to the National TB Reference Laboratory of the Research Institute for Tropical Medicine (NRL-RITM).
DO 2017-0134-A Amendment to Department Order No. 2017-0134 dated April 18, 2017 entitled "Fund Utilization Guidelines for Selected DOH-Retained Hospitals Receiving Sub-Allotment from the National Tuberculosis Control Program for Implementation of TB-HIV Collaboration.
DO 2017-0134 Fund Utilization Guidelines for Selected DOH-retained Hospitals receiving Sub-Allotment from the National Tuberculosis Program for Implementation of TB-HIV Collaboration.
DO 2017-0113 Guidelines on the Sub-allotment and Utilization of Fund for the regionalization of the Philippine Strategic TB Elimination Plan Phase 1 (PhilSTEP1) per request of the Regional Offices.
DO 2017-0097 Sub-Allotment Guidelines for the Release and Utilization of Funds from the Continuing Appropriations 2016 of Implementation of the Doctors to the Barrios - Rural Health Practice Program Funds for the Department of Health Regional Offices V, VIII, XI, XII and DOH-Autonomous Region in Muslim Mindanao.
DO 2017-0057 Guidelines on the Utilization of Fund Sub-allotment to National TB Reference Laboratory (NTRL) – RITM from the Tuberculosis Control Program for the Preparatory Activities for the conduct of the 3rd Drug Resistance Survey (DRS) 2018.
DO 2017-0044 Fund Utilization Guidelines for DOH-retained Hospital in National Capital Region (NCR) receiving Sub-Allotment Fund for the National Tuberculosis Control Program.
DO 2017-0018 Guidelines on Sub-allotment and Utilization of Funds from the National TB Program (NTP) to DOH-National Capital Regional Office (DOH-NCRO) for the Commemoration of 2017 World TB Day.
DO 2017-0015 Guidelines on the Utilization of Fund Sub-allotment to Research Institute for Tropical Medicine (RITM) to Support Integration of Tuberculosis-Paragonimiasis Surveillance.
DO 2017-0011-A Amendment to Department Order No. 2017-0011 dated January 27, 2017 entitled " Guidelines on the Sub-allotment and Utilization of Funds from the National TB Control Program to the DOH Retained Hospitals".
DO 2017-0011 Guidelines on the Sub-allotment and Utilization of Funds from the National TB Control Program to the DOH Retained Hospitals.
DO 2016-0143 Guidelines on the Utilization of Funds Sub-allotment from the National TB Control Program to the National TB Reference Laboratory of the Research Institute for Tropical Medicine (NTRL-RITM).
DO 2016-0106 Guidelines on Fund Transfer to DOH- Autonomous Region in Muslim Mindanao (ARMM) through the Autonomous Regional Governmant (ARG) for the Implementation of Infectious Diseases Control Programs Funded by the Budget Line Items of 1. Elimination of Diseases as Public Health Threat 2. other Infectious Diseases and TB Control Program.
DO 2016-0103 Guidelines on the Utilization of Allotments and Sub-Allotments from the following Budget Line Items: 1. Elimination of Disease as Public Health Threat 2. Rabies Control Program 3. TB Control Program 4. Other Infectious Diseases.
DO 2015-0284 Revised Rules and Procedures on the Preparation and Approval of Administrative Issuances in the Department of Health (DOH).
DO 2015-0084 Guidelines on the utilization of the sub-allotment from the National TB Control Program to DOH-Regional Office 4A (CaLaBaRZon) for the Commemoration of the 2015 World TB Day.
DO 2015-0026 Guidelines on the Utilization of Funds from the following Budget Line Items: 1. Elimination of Diseases as Public Health Threat 2. Rabies Control Program 3. TB Control Program 4. Other Infectious Disease which are "incorporated" in the 2015 DOH Regional Office's budget and RITM including Sub allotment for the implementation of 11 Public Health Programs for the Prevention, Control and Elimination of Infectious Diseases.
Reference Number File Name
DM 2020-0291 Updated Guidelines on Handling of Specimens for Tuberculosis Testing (Xpert MTB/Rif Assay and Smear Microscopy) in the Presence of the Coronavirus Disease (COVID 19) Community Transmission.
INH Advisory Consumption of Isoniazid Syrup for TB Preventive Therapy.
DM 2020-0257 Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation.
DM 2020-0177 Reiteration of Policy on the Implementation of Active TB drug-safety monitoring and management (aDSM).
DM 2020-0147 Utilization of Available Allotment In Response to COVID19 Per RA 1149.
DM 2020-0129 Guidelines on the Use of Xpert MTB/RIF as Primary Diagnostic test for All Presumptive TB.
DM 2020-0128 Ensuring Continuous TB Services During Community Quarantine.
DM 2020-0083 Population Projection to be Used in the Preparation of Statistical Report.
DM 2020-0077 Distribution of Moxifloxacin 400mg tablet to the Programmatic Management of Drug-Resistant Tuberculosis Satellite Treatment Centers.
DM 2020-0074 Implementation of the Key Changes to the Treatment of Drug-Resistant Tuberculosis.
DM 2020-0016 Monthly Reporting of Inventory of TB Commodities through the Integrated Tuberculosis Information System of City, Provincial and Regional Warehouses, Rapid TB Diagnostics Laboratories and Health Facilities Providing TB Services.
DM 2020-0015 Cancellation of the Implementation of the Operational Research entitled "DESTroy TB: Discovering Evidence Supporting the effectiveness of the new Treatment for drug-Resistant Tuberculosis".
DM 2019-0450 Implementation of the Revised Programmatic Management of Drug-Resistant Tuberculosis (PMDT) Guidelines.
DM 2019-0446 Provision of Laptop to all Centers for Health Developments (CHDs), Provincial and (Highly Urbanized) City Health Offices for the data monitoring and validation of Integrated Tuberculosis Information System (ITIS); and to selected Directly Observed Treatment, Short-course (DOTS) facilities for encoding and reporting of Tuberculosis (TB) cases.
DM 2019-0442 Agreements during the National Consultation and Planning for National TB Control Program and National HIV/AIDS and STI Prevention and Control Program held at Davao City last September 16-20, 2019.
DM 2019-0419 Request for Submission of Requirements for the Centralized Application for Continuing Professional Development (CPD) Accreditation at the Department of Health (DOH) for CY 2020.
DM 2019-0387 Implementation of Operational Research entitled "DESTroy TB: Discovering Evidence Supporting the effectiveness of new Treatment for drug-Resistant Tuberculosis".
DM 2019-0353 Recommended Weight-based Dosing of Isoniazid for Latent TB Infection Treatment in Adults.
DM 2019-0342 Monitoring and Reporting of Department of Health (DOH) and Local Government Unit (LGU) Procured Medicines in Health Facilities.
DM 2019-0327 Guidelines on the Referral and Processing of Specimens other than Sputum for Xpert MTB/RIF Assay.
DM 2019-0267 Revised Policy on the Use of Second-line Injectable Agent in the Treatment of Drug-Resistant TB.
DM 2019-0257 Guidelines on Expanded Eligibility for Latent TB Infection (LTBI) Treatment.
DM 2019-0167 Guidelines on Proper Collection, Packaging and Transport of Sputum Specimen for TB Culture and Line Probe Assay (LPA).
DM 2019-0145 Revised Policy on the Use of Xpert MTB/RIF Test.
DM 2019-0097 Interim Guidelines on the Use of the Loop-Mediated Amplification Test for Tuberculosis (TB LAMP) as Rapid Diagnostic Tool in Selected Sites Under the National TB Control Program.
DM 2019-0085 Advisory on Prioritization of Risk Groups for Xpert MTB/RIF Testing and Approach to Presumptive Drug-resistant TB (DR-TB) during the period of Xpert MTB/RIF Cartridge Unavailability.
DM 2019-0077 Guidelines on the Distribution and Use of Point-of-Care Viral Load Tests Using Nucleic Acid Test Principle.
DM 2018-0376 Revised Implementation of Xpert Mycobacterium Tuberculosis Rifampicin (Xpert MTB/RIF) Test.
DM 2018-0333 Amendment of Population to be used in the Preparation of Statistical Reports for CY 2018 - 2022.
DM 2018-0239 Provision of Free Chest X-ray Examination to Persons Deprived of Liberty.
DM 2018-0238 Reiteration of the Department Memorandum No. 2017-0343 dated 7 August 2017 entitled "Guidelines on the Use of Category II Treatment Regimen".
DM 2018-0200 Use of Category II Treatment Regimen for Re-treatment TB Cases among Adults and Modified Category I Treatment Regimen for New TB Cases among People Deprived of Liberty.
DM 2018-0173-A Amendment to Department Memorandum No. 2018-0173 dated 23 April 2018 entitled "Conduct of VALUE-TB Study Philippines and the Support Needed from Concerned Agencies".
DM 2018-0173 Conduct of VALUE-TB Study Philippines and the Support Needed from Concerned Agencies.
DM 2018-0160 Conduct of the Quality of TB Care Study (MEASURE TB) for the National TB Control Program and the Support Needed from Concerned Agencies.
DM 2018-0105 Provision of Certificate of Treatment Completion to Patients with Tuberculosis (TB).
DM 2018-0100 Use of Single-dose Formulation First-line Drugs from Programmatic Management of Drug-resistant TB (PMDT) Treatment Centers for Selected Drug Susceptible TB (DSTB) Patients.
DM 2018-0048 Immediate Distribution of Regional Warehouse Health Commodities for CY 2018.
DM 2018-0038 Submission of Quarterly Inventory Reports starting April 2018.
DM 2018-0031 Updated List of DOH-Designated HIV Treatment Hubs and Primary HIV Care Facilities.
DM 2018-0017 Further Clarifications and Instructions on the Compliance Procedures and Requirements of Republic Act 10173, or the "Data Privacy Act (DPA) of 2012", it's Implementing Rules and Regulations (IRR).
DM 2018-0011 Implementation of the National Online Stock Inventory and Reporting System (NOSIRS) at the Regional Level starting January 15, 2018.
DM 2018-0009 Philippine National Formulary 8th Edition Essential Medicines List 2017.
DM 2018-0005 Implementation of the Approved Medicines in the 8th Edition of the Philippine National Formulary.
ONAR ONAR BULLETIN-7-18-2017.
DM 2017-0487 Nationwide implementation of the Provider Initiated HIV Counselling and Testing (PICT) in all DOTS Facilities.
DM 2017-0476 Guidelines to Standardize the Development of Research and Policy Briefs, Research Summaries and Infographics for Dissemination.
DM 2017-0475 Conduct of the Molecular Diagnosis of Drug Resistant Tuberculosis Study (TBRO1) for the National Tuberculosis Control Program (NTP) and the Support Needed from Concerned Agencies.
DM 2017-0466 Use of 554/100,000 Tuberculosis Incidence Rate as NTPs' Datum.
DM 2017-0420 Call for Abstracts for the 5th Global Symposium on Health Systems Research (HSR2018) and Free Health Systems Global (HSG) Membership.
DM 2017-0372 Conduct of an Assessment on the Quality of TB Diagnosis in the National Capital Region.
DM 2017-0362 Creation of the National and Regional TB Medical Advisory Committees for the Programmatic Management of Drug-Resistant TB (PMDT).
DM 2017-0360 Change in the timeline of submission for the NTP Report 2. Quarterly Report on External Quality Assurance (EQA) for TB Microscopy.
DM 2017-0343 Guidelines on the use of Category II Treatment Regimen.
DM 2017-0338 Guidance in the Observance of the National Tuberculosis Day and National Tuberculosis Awareness Month for CY 2017.
DM 2017-0281 Implementing Guidelines on Programmatic Management Drug-Resistant TB (PMDT).
DM 2017-0272 Issuance of Pharmacovigilance Monitoring System (PViMS) User Account.
DM 2017-0258 Internet Connection for National TB Control Program (NTP) Rapid Diagnostic Laboratories (RTDL), Culture Laboratories, and Drug-susceptibility Test (DST) Laboratories.
DM 2017-0250 Provision of Patient-centered Supervised Treatment for Drug-resistant Tuberculosis.
DM 2017-0238 Implementation of Standard Short Treatment Regimen (SSTR) and Use of Novel Anti-TB Drugs for Drug-resistant TB Patients.
DM 2017-0233 Guidelines on the Use of the Digital X-ray Machine provided by the Global Fund through the Philippine Business for Social Progress (PBSP) in Support of the Objective of the National TB Program (NTP) of Finding All Missing TB Cases.
DM 2017-0228 Guidelines on the Use of Pediatric Fixed Dose Combination (FDC) Anti-TB Drugs in the Treatment of TB in Children.
DM 2017-0176 Clarification on the Definition and Enhancing the Recording of "Sources of Cases" for the National TB Program Recording for Form 4. TB Treatment/IPT Card and Form 6. TB Register.
DM 2017-0175 Pilot Implementation of GX Alert System.
DM 2017-0174 Harmonization of the National Tuberculosis Control Program (NTP) Programmatic Indicators with Field Health Services Information System (FHSIS).
DM 2017-0152 Cancellation of Drug Holiday During Treatment of Drug-resistant TB.
DM 2017-0147 Guidance in the Observance of the World TB Day for CY 2017.
DM 2017-0137 Designation of Data Protection Officer or Compliance Office for Privacy.
DM 2017-0130 Feedback of the National Tuberculosis Program Year Start National Consultative Workshop held at Bali Village Hotel, Tagaytay City last February 7-9, 2017.
DM 2017-0075 World TB Day Commemoration on March 24, 2017.
DM 2017-0073 Population to Be Used in the Preparation of Statistical Reports for CY 2017-2021.
DM 2017-0058 Change of storage sondition for Aminosalicylic Acid Delayed-Release Granules (PASER Granules).
DM 2017-0035 Utilization of 322/100,000 Tuberculosis (TB) Incidence Rate in the computation of the Case Detection Rate (CDR) in 2016.
DM 2017-0014 Implementing Rules and Regulations of Republic Act NO. 10767 Otherwise Known as "Comprehensive Tuberculosis Elimination Plan Act of 2016".
DM 2016-0423 Prescribed lay-out and usage of DOH and "All for Health Towards Health For All" logos on letters, formal documents, T-shirts, vest, IEC materials and other collateral materials.
DM 2016-0403 Implementation of the Approved Medicines in the 8th Edition of the Philippine National Formulary.
DM 2016-0395 Use of new Department of Health Letterhead in all Outgoing Official Correspondence of this Department.
DM 2016-0383 Use of Bedaquiline in the Treatment of Drug-resistant Tuberculosis under Program Condition.
DM 2016-0382 Province-wide Implementation of Provider Initiated HIV Counseling and Testing in Pampanga and Cavite.
DM 2016-0335-A Amendment to Department Memorandum No. 2016-0335 regarding Conduct of the Catastrophic cost study for the National TB Control Program (NTP) and the support needed from Concerned Agencies.
DM 2016-0335 Conduct of the Catastrophic Cost Study for the National TB Control Program (NTP) and the Support Needed from Concerned Agencies.
DM 2016-0334 Used of the Integrated Tuberculosis Information System (ITIS) for Submission of All NTP Quarterly Reports.
DM 2016-0285 Implementation of Xpert MTB/RIF Test as the Primary Diagnostic Tool for Presumptive Drug-Resistant Tuberculosis (DR-TB) and Presumptive Drug Susceptible Tuberculosis (DSTB) among Selected Vulnerable Populations.
DM 2016-0283 Monitoring of the Monthly Utilization and Inventory of All DOH Procured Medicines.
DM 2016-0276 Guidelines for DOH Publications.
DM 2016-0273 Observance of the August 2016 National Lung Month with theme: "END TB: SAMA-SAMANG Hanapin, Gamutin, Pagalingin LAHAT".
DM 2016-0221 Use of Revised NTP Laboratory Recording and Reporting Forms and Timeline of Submission of NTP Laboratory Quarterly Report.
DM 2016-0188 Updated List of DOH-Designated HIV Treatment Hubs and Satellite Treatment Hubs.
DM 2016-0133 Integration of Programmatic Management of Drug-resistant Tuberculosis (PMDT) Services into Basic Directly Observe Treatment Short course (DOTS) Services in Health Facilities.
DM 2016-0119 Collection of Data for Australian Tuberculosis Modeling Network (Autumn)/Optima TB by the National TB Control Program (NTP).
DM 2016-0059 Recording and Reporting of Hospital TB DOTS Indicators.
DM 2016-0043 Lifting of Department Memorandum No. 2015-0356: Temporary Change in the Standard Treatment Regimen for Drug Resistant TB Cases and Drug Stock Level to be Provided to Treatment Sites (TS) and IDOTS Facilities.
DM 2016-0034 Classification of Tuberculosis (TB) Disease Based on Bacteriological Status of Drug-Resistant Cases.
DM 2016-0028 Adjusted Tuberculosis (TB) Incidence Rate for 2016.
DM 2016-0026 Support Needed for the Conduct of the 2016 National TB Prevalence Survey (NTPS).
DM 2015-0356 Temporary Change in the Standard Treatment Regimen for Drug Resistant TB Cases and Drug Stock Level to be Provided to Treatment Sites (TS) and IDOTS Facilities.
DM 2015-0339 New Uniform for DOH Employees for CY 2016-2018.
DM 2015-0325 Updates on the Procurement of CAT II Anti-TB Medicines and Request for Procurement of Streptomycin and Ethambutol.
DM 2015-0321 Updates on the Procurement of TB Medicine in Children.
DM 2015-0304 Change of Storage Condition for Para-Aminosalicylic Acid Delayed-Release Granules (PASER Granules).
DM 2015-0294 Revised Clinical and Laboratory Baseline and Follow-up for Drug Resistant Tuberculosis (DR-TB) Patients.
DM 2015-0271 Full Implementation of Xpert MTB/RIF under the Revised NTP MOP for Case Finding of All Types of TB.
DM 2015-0270 Submission of Xpert MTB/RIF On-Site Evaluation Checklist for the 2015 Rollout and Name of Personnel to be Trained for Xpert Processing.
DM 2015-0260 Revised Diagnostic Algorithm Using Xpert MTB/RIF.
DM 2015-0233 Guide for 2015 NTP Reporting of Treatment Outcomes of 2014 Drug-Susceptible TB Patient Cohort.
DM 2015-0228 Expanded List of PMDT Ancillary Drugs.
DM 2015-0200 Implementation of Operational Research Entitled "Feasibility, Effectiveness and Safety of 9-Month Treatment Regimen for Multi Drug-resistant Tuberculosis in the Philippines".
DM 2015-0185 Submission of National Tuberculosis Control Program (NTP) Reports Using Integrated TB Information System (ITIS) for PMDT Treatment Facilities.
DM 2015-0176 Development and Use of the Integrated Tuberculosis Information System (ITIS) Laboratory Module.
DM 2015-0114 Collection of Treatment Outcome of TB Patients for the "Surveillance of Moxifloxacin and Pyrazinamide Resistance among TB Patients in the Philippines".
DM 2015-0110-A Amendment of Department Memorandum No. 2015-110 Which Provides for the Product Recall Order of Rifampicin (RIFANID) Suspension 200mg/5mL.
DM 2015-0110 Product Recall Order of Rifampicin (RIFANID) Suspension 200mg/5mL.
DM 2015-0100 Advisory on the distribution of Ziehl-Neelsen staining kits expiring in 2015.
DM 2015-0095 Adjustment of TB-HIV Cohort Reporting and Regional Coordination on HIV Testing Kits for NTP.
DM 2015-0094 Hiring of NTP Data Officers for Regional NTP.
DM 2015-0085 Initiation of P-Aminosalicylate Sodium to Newly Enrolled Drug Resistant TB (DR-TB) Cases.
DM 2015-0073 Prescribe Lay-out and Usage of DOH Logo on T-Shirts, Vest and Collaterals.
DM 2015-0069 Utilization of Adjusted TB Incidence Rate for 2015.
DM 2015-0065 Kick-Off Activity for 2015 World TB Day and Meeting/Discussion with Regional Directors, ARMM Secretary and Respective Budget Officers on the 2015 Budget of the Disease Prevention and Control Bureau (DPCB) on March 16, 2015 at DOH Central Office.
DM 2015-0044 Designation of regional point-person for TB-HIV Collaboration.
DM 2015-0025 Implementation of "Feasibility, effectiveness, and safety of 9-month treatment regimen for multidrug-resistant tuberculosis in the Philippines" operational research.
DM 2015-0018 Call For Application to the Fundamentals of Operational Research.
Reference Number File Name
DPO 2019-4526 Authority of Integrated Tuberculosis Information System (ITIS) personnel of Knowledge Management and Information Technology Service (KMITS) to conduct monitoring visits to Provincial/City Health Offices (PHOs/CHOs), Rural Health Units (RHUs), Programmatic Management of Drug Resistant TB (PMDT) Treatment Centers/Satellite Treatment Centers of Region VIII(Eastern Visayas) from October 14-18, 2019.
DPO 2019-4488 Authority for Selected Department of Health Personnel to Participate in the National Joint Program Review on September 30 to October 8, 2019.
DPO 2019-3530 Designation of DOH Technical Staff for Advancing Health through Evidence-Assisted Decisions with Health Policy and Systems Research (AHEAD wtih HPSR) Studies.
DPO 2018-0377 Creation of 3rd Philippine Tuberculosis Drug Resistance Survey (DRS3) Project Team.
DPO 2016-4480 Reconstitution of the Technical Working Groups (TWGs) for HIV/AIDS, Tuberculosis and Malaria (ATM).
DPO 2016-2987 Organization of the Steering Committee and Task Force on the Development of the National Strategic Plan towards TB Elimination.
DPO 2016-2225 Attendance of selected DOH-Central Office Staff, Chief of Hospitals, Regional NTP Coordinators, PMDT Treatment Facility Staff and Partners to the Evaluation of the Operational Research entitled "Feasibility, Effectiveness, and Safety of 9-Month Treatment Regimen for Multidrug-Resistant Tuberculosis in the Philippines" on August 3-5, 2016 (exclusive of travel time) in Metro Manila.
DPO 2016-1396 Creation of the Oversight Committee for the Programmatic Management Drug Resistant Tuberculosis (PMDT) Researches Using Novel TB Drug and Treatment Regimen.
DPO 2015-4070 Creation of the Steering Committee and Technical Working Group for the 2015 National TB Prevalence Survey.
DPO 2011-2300 Creation of the 2nd TB Drug Resistance Surveillance (DRS) Team.
DPO 2011-0888 Creation of TB Task Force for Special Studies.
DPO 2006-1869 Creation of National TB/HIV Collaborating Committee.
DPO 2006-1827 Creation of the Steering Committee for the 2007 National TB Prevalance Survey (3rd NPS).
DPO 2005-0405 Creation of the Council for the Clinical Management on Multi-Drug Resistant Tuberculosis (MDRTB).
Reference Number File Name
20160426-RA-10767-BSA-Signed Version An Act Establishing a Comprehensive Philippine Plan of Action to Eliminate Tuberculosis as a Public Health Problem and Appropriating Funds Therefor (Signed Version).
20160426-RA-10767-BSA-PDF Version An Act Establishing a Comprehensive Philippine Plan of Action to Eliminate Tuberculosis as a Public Health Problem and Appropriating Funds Therefor (PDF Version).
MC 2017-0014 Implementing Rules and Regulations of Republic Act No. 10767 Otherwise Known as "Comprehensive Tuberculosis Elimination Plan Act 0f 2016" .
MC 2017-0002 Letter from the Philippine Statistics Authority Requesting Submission of Proposed and/or Sponsored Survey for Technical Review Clearance.
MC 2016-0013 Republic Act (RA) No. 10767 entitled "An Act Establishing a Comprehensive Philippine Plan of Action to Eliminate Tuberculosis as a Public Health Problem and Appropriating Funds Therefor".
MC 2015-0002-A Amendment to Memorandum Circular No. 2015-0002 Dated January9, 2015 Entitled: "Revision of the Reporting System for the Newly-Diagnosed People Living with HIV (PLHIV), Baseline Assessment for Art Eligibility, HIV Care, Treatment, and Mortality in Accordance with the New National Art and TB-HIV Guidelines".
MC 2015-0002 Revision of the Reporting System for the Newly Diagnosed People Living with HIV (PLHIV), Baseline Assessment for Art Eligibility, HIV Care, Treatment, and Mortality in Accordance with the New National Art and TB-HIV Guidelines.
MC 2006-0017 Attendance to the "Celebration of the World TB Day" on March 24, 2006 at the Quezon City Memorial Circle.
DC 2017-0354 Single Joint Ethics Review Standard Operating Procedures.
DC 2017-0133 2nd Scientific Symposium on "An Advocacy Effort for Childhood TB of the Center for Tuberculosis in Children, Philippines A Foundation Inc. in collaboration with the Department of Pediatrics, Fe Del Mundo Medical Center on June 21, 2017 at the Dr. Fe Del Mundo Medical Center, Medical Arts Bldg., 3/F Rm. 301 Candiz cor., Banawe St. Quezon City.".
DC 2016-0171 Enhancing Linkage to care of People Living with HIV (PLHIV).
DC 2015-0243 Pediatric TB DOTS Training and Workshop of the Lung Center of the Philippines on 06-07 August 2015 at the Audio Visual Room Ground Floor, LCP, Diliman, Quezon City
DC 2011-0138 Estimated Population for CY 2011-2014.
DC 2009-0049 World TB Day Celebration.
DC 2006-0246 13th Annual Philippine Coalition Against TB (PhilCAT) Joint Convention with the Philippine College of Chest Physicians (PCCP) from August 17-19, 2006 at Taal Vista Hotel, Tagaytay City.
DC 2005-0165 2005 TB Awareness Program of the Philippine Academy of Pediatric Pulmonologists, Inc.
DC 238-03 Guidelines on the Use of Fixed-Dose Combination (FDC) Anti-TB Drugs under the National TB Program (NTP).
DC 207-04 TB Awareness Program of the Philippine Academy of Pediatric Pulmonologists, Inc.
DC 169-04 Training on the National TB Program (NTP) by the Department of Education (District Levels) in Coordination with the Department of Health.
DC 157-02 Post Doctoral Position Available in TB at the New Jersey Medical School.
DC 104-04 Adoption of the "Operational Guidelines for the Public-Private Mix DOTS in the Philippines" under the National TB Program.
PhilHealth Circular Revised Guidelines for the Philhealth Outpatient Anti-Tuberculosis Directly Observe Treatment Short-Course(DOTS) Benefit Package.